The organization rounds out its executive leadership team, welcoming Susan Byrd, MHRD, as chief human resources officer and Keith Hennegan, MBA, as chief operating officer.

NASHVILLE, Tenn. – Dec. 11, 2023 – AMSURG, a leader in ambulatory surgery center services, announces two appointments to its executive leadership team. Susan Byrd, MHRD, has been appointed as chief human resources officer (CHRO) at AMSURG, officially joining the organization on Dec. 4. Additionally, Keith Hennegan, MBA, has been appointed as chief operating officer (COO), assuming the position effective today.

AMSURG welcomes Byrd and Hennegan to the organization, where their experience, expertise and leadership will play a key role in guiding the growth, development and success of the company’s teams and services in the years to come.

“Susan and Keith bring a passion for serving and developing others to our executive team,” said Jeff Snodgrass, president and chief executive officer of AMSURG. “They are both committed to our organization’s mission and values, and I’m excited for our teams to benefit from their proven leadership, which will ultimately have a positive impact on the value and experience we provide patients.”

As the CHRO of AMSURG, Byrd brings more than 25 years of human capital experience, building strategies for growth, change and company culture in public and private settings. Before joining AMSURG, she served as chief people officer at SpecialtyCare. Byrd has also held HR roles in and out of the health care sector, including as senior vice president of human resources at Change Healthcare (previously Emdeon), as well as Dell Computers, SunTrust Bank and Bosch. Byrd is also a published author, writing Human Resources Leadership, Alignment, and Trends—Inside the Minds: HR Leadership Strategies and The Accountable Human Resources Department: Delivering Strategic Programs That Contribute to the Bottom Line.

“As a people leader for more than three decades, I’m honored to join AMSURG and excited to work with such talented and passionate employees and team members,” Byrd said. “This is an exciting time of growth and innovation for the organization and everyone who is a part of it, and I look forward to continuing the organization’s focus of being a great place to work for all.”

Serving as COO of AMSURG, Hennegan has extensive experience in multisite health care operations, mergers, acquisitions and investing. Before joining AMSURG, Hennegan was the COO at US Fertility, where he led operations, human resources and marketing for the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices. He held multiple roles with DaVita Inc., where he oversaw a portfolio of clinics in Louisiana and southeast Texas, most recently as division vice president. Before transitioning into health care, Hennegan worked at RoundTable Healthcare Partners, a middle-market private equity fund, and was in the global mergers and acquisitions investment banking group at Deutsche Bank.

“It’s a pleasure to join the AMSURG leadership team and be a part of advancing the organization’s commitment to continuous improvement, operational excellence and growth,” Hennegan said. “AMSURG has proven to be a leader in the ambulatory surgery center space, providing high-quality care and experiences to patients. I’m looking forward to the many opportunities ahead for the organization to impact patients, teammates and physician partners.”

With this announcement, AMSURG rounds out its executive leadership team.

About AMSURG

AMSURG is an independent leader in ambulatory surgery center services, operating a network of more than 250 surgery centers nationwide. In partnership with physicians and health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care and services. To learn more about AMSURG, visit www.amsurg.com.

###

The organization adds seven healthcare industry and business professionals to its Board of Directors.

NASHVILLE, Tenn. – Nov. 30, 2023 – AMSURG, a leader in ambulatory surgery center services, announced appointments to the organization’s Board of Directors. The announcement comes after a successful emergence as an independent company under new leadership and positioned for growth.

Seven members will serve on the AMSURG Board of Directors:

• David King, previous chairman, CEO and president of LabCorp who led the organization’s transformation into a leading global life sciences company. Under King’s leadership, LabCorp completed a series of successful acquisitions, tripling the company’s size to 60,000 employees operating in 120 countries. The company’s share price increased by more than 125% during King’s time as CEO. King has been appointed as chair of the AMSURG Board of Directors, and he will also serve on the Compensation Committee.
• Jeff Snodgrass, president and CEO of AMSURG who recently led the organization through a successful restructuring process. Before AMSURG, Snodgrass served as president and CEO of Azura Vascular Care and National Cardiology Partners, leading the organization to unprecedented growth and transformation from an office-based outpatient business to an ambulatory surgical care company. Snodgrass also served as chief financial officer at inVentiv Health, and he spent more than 17 years at Merck & Co. in several leadership positions in finance and marketing.
• Molly Joseph, former CEO of UnitedHealthcare Global. During her 16-year tenure at UnitedHealth Group, she pioneered the establishment of the company’s global health business into one of the largest health benefits and medical delivery businesses outside of the United States. She also oversaw 55 hospitals and several hundred ambulatory centers, with over nine million patients and seven million insurance members. Currently, Joseph is the founder and managing partner of Cypress Pass Ventures, an investment and advisory firm focused on health modernization. She also serves on the Board of Directors of West Pharmaceutical Services, First Solar and U.S. Radiology Specialists and is vice-chair of the Board of Trustees at Santa Clara University.
• Adam Hieber, executive vice president and global head of corporate asset management at PIMCO. Before PIMCO, he was an operating partner and head of portfolio performance management for SoftBank and managing director and president of Cerberus Capital Management’s global operating team. He has also held numerous board appointments and senior management positions including chairman, CEO, CFO and CRO. He has been appointed Chair of the AMSURG Compensation Committee.
• Joel Day, former chief financial officer at Kindred Healthcare and Scion Healthcare. In these roles, Day successfully led significant value creation initiatives, partnered with multiple private equity firms to complete a company sale and the formation of a new company and provided support and oversight on a 15-hospital acquisition. Before serving as CFO, Day spent 25 years in various finance leadership roles with Kindred Healthcare, including as operations CFO for six years, where he was responsible for the support and operational results of seven business lines with over $7 billion in revenue. In addition to serving as an AMSURG board member, Day will serve on the AMSURG Audit Committee.
• Lisa A. Pollina, former vice chairman for RBC Capital Markets. Pollina has been named a ‘Top 25 Most Powerful Women in Finance’ by American Banker and has negotiated over $50 billion in corporate development deals globally throughout her career. She serves on the Board of Directors for Munich RE representing the Americas, as well as the Board of the Atlantic Council of the United States. She is also a member of the Council on Foreign Relations and an advisor to ARES Management. Pollina has extensive corporate board and committee experience and has been appointed Chair of the AMSURG Audit Committee.
• Leopoldo Quintas Jr., former three-star deputy commanding general of U.S. Army Forces Command. In this role, Quintas led day-to-day operations of the Army’s largest organization, comprised of more than 750,000 soldiers and civilians. Under his leadership, the organization transformed its readiness and operations to achieve unprecedented modernization while sustaining uninterrupted support to worldwide requirements. He has more than three decades of experience training, equipping and supporting personnel and employing capabilities, to include conduct of comprehensive health care both at home and abroad. Today, Quintas serves on the board of the West Point Association of Graduates and continues to support the U.S. Army as a highly qualified expert.

“I am thrilled to have such seasoned and accomplished professionals serving on the AMSURG Board of Directors,” said Jeff Snodgrass, president and CEO of AMSURG. “These leaders provide a wealth of industry knowledge and business expertise that complements our strong leadership team. I look forward to working alongside them to enhance our growth opportunities and continue to provide quality care for patients.”

The board composition underscores AMSURG’s commitment to continue to advance its leadership in high quality ambulatory surgery care. The Board of Directors will play a key role in providing strategic counsel and guidance to AMSURG leaders as the organization focuses on growth, innovation and delivering high-quality patient care.

“It is an honor to join the AMSURG Board of Directors,” said David King, chair of AMSURG’s Board of Directors. “AMSURG is a leader in the ambulatory surgery center space that is poised for growth and innovation. I am excited to partner with the leadership team on the many opportunities ahead for the organization.”

About AMSURG

AMSURG is an independent leader in ambulatory surgery center services, operating a network of more than 250 surgery centers nationwide. In partnership with physicians and health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care and services. To learn more about AMSURG, visit www.amsurg.com.

###

The organization exits the financial restructuring process poised for growth and focused on the future.

Nashville, Tenn. – AMSURG, a leader in ambulatory surgery center services, announced today its successful emergence from its restructuring process. AMSURG emerges under new ownership as a separate and independent entity from Envision Healthcare. This marks a new chapter in AMSURG’s history, focused on growth, innovation and delivering high-quality patient care across a diverse spectrum of medical specialties—from gastroenterology to ophthalmology and orthopedics.

This transition provides AMSURG with unique opportunities to elevate its operations, build on recent successes, and enhance its strategic focus. As a result of its successful emergence from its restructuring process, current AMSURG President Jeff Snodgrass will now serve as AMSURG President and CEO.

“Today begins an exciting new era for our organization,” said Snodgrass. “AMSURG is at a critical point in our history with a bright path ahead of us for growth and innovation in the ambulatory surgery space. We are looking forward to expanding our footprint, investing in our infrastructure and our teams, and enhancing value for our centers and patients.”

AMSURG will focus on 4 key objectives for its future growth and development:

1. Commitment to High-Quality Patient Care: The company remains steadfast in its dedication to maintaining the highest standards of patient care, safety and satisfaction as it continues to expand its suite of services. AMSURG is poised and committed to embracing cutting-edge technologies and innovative healthcare solutions to support its physician partners, improve operational efficiency and enhance patient experiences.
2. Cultivating Strategic Partnerships: AMSURG will continue to actively seek strategic partnerships and collaborations with healthcare providers, payors and other stakeholders to foster innovation, drive healthcare excellence and improve care for patients.
3. Enhanced Financial Stability: AMSURG’s successful restructuring has fortified its financial position, building upon its solid foundation for sustained growth and strategic investments.
4. Teammate Development: Recognizing the pivotal role its teammates play in driving success, AMSURG is committed to investing in the growth and development of teammates in and beyond its centers, reflecting the organization’s dedication to nurturing a skilled and empowered workforce.

“I am incredibly proud of the team here at AMSURG for their hard work and dedication to our centers, our partners and our patients,” added Snodgrass. “This process has required an unmatched level of teamwork and thoughtfulness—thank you to all who played a part. I am also grateful to the physician partners and staff in our centers for their unwavering commitment to delivering high-quality patient care.”

About AMSURG

AMSURG is an independent leader in ambulatory surgery center services, operating a network of more than 250 surgery centers nationwide. In partnership with physicians and health systems, the organization delivers high-quality care for patients across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care and services. To learn more about AMSURG, visit www.amsurg.com.

For media inquiries, please contact media@amsurg.com.